There’s been a lot of mixed news about the AstraZeneca vaccine over the past months. In some countries in Europe, the vaccine was put on pause, while other countries never stopped using it. Now, there is new data out: According to a clinical trial conducted in the US, AstraZeneca’s vaccine was found to be 79% effective. Host Marco Werman talks with Dr. Miguel Nicolelis, based in São Paulo, Brazil.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.